Published in J Pediatr Intensive Care on June 22, 2015
Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis | NCT01365793
Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med (2001) 5.06
Assessing the outcome of pediatric intensive care. J Pediatr (1992) 4.92
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res (2000) 3.84
GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology (2010) 2.52
Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med (2008) 2.27
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes (2004) 2.03
Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? Pediatr Diabetes (2007) 1.97
The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child (2001) 1.86
Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes (2006) 1.86
Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children. Crit Care Med (2006) 1.84
Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child (1999) 1.81
Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med (2010) 1.76
European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics (2004) 1.71
Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care (2003) 1.67
GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma (2004) 1.65
Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care (1990) 1.43
Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care (2011) 1.42
Genetic influences on outcome following traumatic brain injury. Neurochem Res (2007) 1.28
Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol (1999) 1.23
Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr (2010) 1.20
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation (2003) 1.16
Therapeutic hypothermia after pediatric cardiac arrest trials: the vanguard phase experience and implications for other trials. Pediatr Crit Care Med (2013) 1.15
Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr (1998) 1.14
Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med J (2005) 1.12
Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr (2005) 1.11
Systematic review of clinical research on biomarkers for pediatric traumatic brain injury. J Neurotrauma (2013) 1.10
Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol (2006) 1.10
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care (2001) 1.03
Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care (2004) 1.00
Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res (2008) 0.96
Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol (2003) 0.96
Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci (2010) 0.94
Translational research in pediatrics II: blood collection, processing, shipping, and storage. Pediatrics (2013) 0.87
Predicting cerebral edema during diabetic ketoacidosis. N Engl J Med (2001) 0.86
Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction. Microcirculation (2013) 0.86
Age-specific analysis of normal cytokine levels in healthy infants. Clin Chem Lab Med (2003) 0.84
Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury. Neurocrit Care (2014) 0.82
Cognitive dysfunction associated with diabetic ketoacidosis in rats. Neurosci Lett (2012) 0.82
CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitro. Am J Physiol Endocrinol Metab (2014) 0.79
Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis. Pediatr Crit Care Med (2004) 0.78
Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms. Eur Cytokine Netw (2005) 0.78
Reference ranges for neuroprotein S-100B: from infants to adolescents. Clin Chem Lab Med (2008) 0.77
Cerebral edema in diabetic ketoacidosis: an underestimated complication? Pediatr Diabetes (2006) 0.76
Predominance of DR3 in Somali children with type 1 diabetes in the twin cities, Minnesota. Pediatr Diabetes (2016) 0.75